Sunburn

L12_SUNBURN

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L55 Hospital discharge: ICD-9 — 6927A Cause of death: ICD-10 — L55 Cause of death: ICD-9 — 6927A 2 out of 7 registries used, show all original rules.	86
4. Check minimum number of events None	86
5. Include endpoints None	86
6. Filter based on genotype QC (FinnGen only)	74

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L55-L59
Name in latin: Erythema solare

NAME	L12_SUNBURN
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L55
HD_ICD_9	6927A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L55
COD_ICD_9	6927A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sunburn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	631	298	326
Only index persons	553	272	281
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	37.42	44.67	30.51
Only index persons	36.73	43.53	30.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	74	38	36
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	45.39	46.94	43.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
76: Matched controls
760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L55.9

ICD-10 Finland

Sunburn, unspecified

+∞

36.4

L55.0

ICD-10 Finland

Sunburn of first degree

+∞

21.9

L55.8

ICD-10 Finland

Other sunburn

+∞

11.8

L55.1

ICD-10 Finland

Sunburn of second degree

+∞

8.5

6927A

ICD-9 Finland

Contact dermatitis and other eczema, Due to solar radiation[ERYTHEMA SOLARE]

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022948) Iron [Moles/volume] in Serum or Plasma

3.35

5.18

3.6

2.3

11.38

13.76

umol/l

1.10

(3000991) Gas panel - Venous blood

3.57

4.07

6.2

8.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

188

2.60

3.96

3.4

2.0

342.40

169.53

u/l

0.34

181

(3012544) pH of Venous blood

3.23

3.69

5.8

2.8

7.37

7.40

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.81

3.57

3.9

2.2

2.31

2.37

g/l

0.16

(3023368) Bacteria identified in Blood by Culture

167

2.45

3.39

5.9

4.0

—

(3000494) Fungus identified in Specimen by Culture

2.69

3.21

1.3

1.4

—

(3021589) Normoblasts [#/volume] in Blood

292

2.33

3.17

16.1

10.6

0.00

e9/l

0.50

243

(3026493) Urate [Moles/volume] in Serum or Plasma

174

2.32

3.04

3.6

2.7

362.28

333.15

umol/l

0.64

152

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

10.57

3.02

2.2

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

7.12

2.92

1.3

1.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

387

2.37

2.91

5.8

4.6

6.39

6.62

mmol/l

0.63

363

(3006315) Basophils [#/volume] in Blood

324

2.18

2.70

9.5

6.5

0.04

e9/l

0.27

286

(3001604) Monocytes [#/volume] in Blood

324

2.18

2.70

9.6

6.5

0.64

0.56

e9/l

1.33

286

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2.63

7.4

3.5

1.05

1.00

mmol/l

0.71

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.45

2.60

2.7

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2.87

2.60

6.8

8.2

2.07

1.05

mmol/l

1.75

(3028707) Methadone [Presence] in Urine by Screen method

5.81

2.59

7.3

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

380

2.17

2.49

12.4

10.9

4.75

4.14

e9/l

1.02

340

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

5.32

2.45

2.0

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

333

2.08

2.41

9.4

6.4

1.93

1.82

e9/l

0.41

302

(4062490) Immunoglobulin typing, IgG

6.59

2.41

1.4

1.1

—

(3013115) Eosinophils [#/volume] in Blood

337

2.03

2.29

9.8

6.5

0.21

0.20

e9/l

0.27

304

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

5.85

2.25

1.4

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

5.85

2.25

1.4

1.1

—

(42870588) Differential panel, method unspecified - Blood

210

2.01

2.24

9.5

5.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

4.55

2.19

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3.15

2.15

2.2

2.4

25.00

24.95

mmol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.74

2.11

2.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

5.26

2.10

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

101

2.17

2.04

3.2

1.04

0.86

e6/l

0.18

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.35

2.03

2.2

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.19

2.00

11.0

11.6

25.06

24.69

mmol/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.78

1.97

1.0

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

150

1.99

1.96

1.8

1.6

1.09

0.84

mg/l

0.20

120

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.12

1.86

3.2

3.3

2.59

2.37

e6/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

4.38

1.85

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.96

1.85

4.9

3.5

0.60

0.63

—

(3022145) Colonoscopy Study observation

2.25

1.85

1.1

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.21

1.79

2.0

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.15

1.76

1.9

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

4.04

1.74

1.0

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.76

1.71

4.9

3.5

1.15

1.55

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

255

1.78

1.65

8.4

6.0

1.20

1.21

mmol/l

0.11

243

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.16

1.61

2.9

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.04

1.56

7.9

7.5

105.31

103.40

mmol/l

1.01

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.75

1.55

6.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.49

1.55

1.2

1.5

176.80

220.60

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.01

1.54

1.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

172

1.78

1.47

4.7

3.0

0.15

0.41

e6/l

1.06

131

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.87

1.46

2.5

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.07

1.38

1.6

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

3.07

1.38

1.6

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.25

1.34

1.3

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

212

1.69

1.33

2.5

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

482

1.73

1.23

3.8

4.6

14.88

14.81

pmol/l

0.08

453

(3024561) Albumin [Mass/volume] in Serum or Plasma

263

1.61

1.20

4.7

4.3

35.00

36.12

g/l

0.48

250

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

122

1.74

1.17

1.8

1.4

0.98

11.93

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.60

1.17

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.60

1.17

11.6

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

237

1.60

1.16

4.1

3.6

18.10

49.67

ng/l

1.07

150

(3031040) Bacteria [#/volume] in Urine by Automated count

402

1.62

1.15

5.3

4.4

—

625.50

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

249

1.57

1.09

2.5

1.9

91.20

95.73

pmol/l

0.16

120

(40760892) CBC W Ordered Manual Differential panel - Blood

159

1.64

1.08

4.7

6.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

142

1.66

1.07

2.6

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.02

1.07

2.3

1.5

—

(3022313) Gas panel - Capillary blood

2.36

1.05

1.8

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2.10

1.03

7.4

3.3

0.83

0.93

—

(3032080) INR in Blood by Coagulation assay

291

1.53

1.00

26.4

12.1

1.27

1.18

inr

0.43

239

(3016879) Cocaine [Presence] in Urine

2.04

1.00

6.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.04

1.00

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.98

0.97

6.4

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

333

1.50

0.94

4.9

3.8

0.00

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

147

1.59

0.93

2.4

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

645

2.08

0.92

30.9

14.5

26.33

21.99

mg/l

0.42

526

(3035350) Ketones [Presence] in Urine by Test strip

335

1.49

0.90

4.7

3.9

0.00

estimate

-0.00

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

131

1.60

0.90

1.8

1.3

37.54

23.82

iu/ml

—

(40768443) Skin Pathology biopsy report

2.08

0.89

1.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.82

0.85

8.9

8.5

21.96

24.87

mmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

107

1.63

0.85

1.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.95

0.83

2.5

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

339

1.45

0.82

5.0

3.9

0.00

0.07

estimate

0.49

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.80

0.0

2.5

—

3.49

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.83

0.78

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

127

1.55

0.77

6.1

3.2

205.33

440.91

ng/l

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.87

0.75

7.9

3.2

1.36

1.56

—

(3027008) Opiates [Presence] in Urine

1.87

0.75

6.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1.87

0.75

6.6

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.07

0.74

3.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

182

1.47

0.74

5.1

3.8

0.00

estimate

-0.00

(3018095) Leukocytes [#/volume] in Urine

230

1.42

0.70

5.8

3.8

103.95

49.02

e6/l

0.25

165

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.65

0.67

1.6

2.0

1.79

6.37

ug/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.63

0.63

1.8

2.3

0.36

0.12

e6/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

197

1.40

0.62

3.2

3.1

1445.86

851.16

ng/l

0.30

165

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

652

0.67

0.59

6.9

5.3

2.78

2.77

mmol/l

0.03

614

(3027944) Amphetamines [Presence] in Urine

1.58

0.54

7.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

155

1.39

0.54

2.2

1.3

2.20

2.65

g/l

0.42

(3026008) Bacteria identified in Urine by Culture

183

1.37

0.53

3.9

2.9

—

(3019977) pH of Arterial blood

1.51

0.53

9.5

7.1

7.43

7.42

—

(3015736) pH of Urine

269

1.33

0.52

4.4

3.6

6.02

6.20

0.59

159

(3011397) Hemoglobin [Presence] in Urine by Test strip

139

1.39

0.49

3.9

4.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

195

1.34

0.49

6.1

3.6

5.30

10.79

mg/mmol

0.66

127

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.60

0.49

1.8

2.1

4.56

3.54

ratio

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

0.57

0.49

5.8

2.7

9.74

9.35

umol/l

—

(3013512) EKG study

186

1.34

0.48

6.3

3.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.47

0.48

3.3

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

441

1.31

0.48

3.7

3.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

196

1.33

0.47

4.5

3.2

0.33

0.02

estimate

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

264

1.29

0.45

2.0

1.9

1.47

1.34

mmol/l

0.32

219

(40758558) Short blood count panel - Blood

207

1.31

0.44

8.0

6.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.65

0.44

1.0

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1.60

0.43

2.4

1.7

—

6.89

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

591

1.39

0.43

5.8

5.3

1.88

1.96

mu/l

0.25

552

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.50

0.41

3.6

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.40

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.40

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.40

0.0

1.4

—

1.02

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.40

0.0

1.4

—

1.06

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.40

0.0

1.4

—

1.39

—

(3012516) Albumin [Mass/volume] in Urine

192

1.28

0.38

4.8

3.1

24.62

67.45

mg/l

1.31

131

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

310

1.24

0.35

2.6

—

estimate

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.39

0.35

2.2

1.6

—

(3003694) ABO and Rh group [Type] in Blood

206

0.77

0.35

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.38

0.34

2.0

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

253

1.24

0.33

5.1

3.7

0.20

0.00

estimate

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.35

0.32

3.0

8.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.33

0.31

1.1

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.28

0.24

3.3

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

4.2

—

18.73

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.9

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

4.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.4

—

27.18

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

45.02

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.20

0.0

2.6

—

6.13

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.5

—

(3019150) Specific gravity of Urine by Refractometry

139

1.19

0.18

5.7

4.2

1.02

kg/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

130

1.19

0.17

1.5

—

(3002256) Pathology report gross observation

1.19

0.16

1.2

—

(40768804) Tissue Pathology biopsy report

260

1.12

0.13

2.4

1.9

—

(1761868) Lipid panel - Serum or Plasma

287

0.91

0.10

3.7

3.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.10

0.09

2.0

3.3

—

(4035726) Immunohistochemistry procedure

1.08

0.09

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.10

0.08

1.4

1.6

—

(3042936) Bacteria identified in Isolate by Culture

0.87

0.07

2.9

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.09

0.02

1.2

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

614

1.05

0.00

6.1

4.5

5.95

5.94

mmol/l

0.02

568

(40768797) Stomach Pathology biopsy report

1.04

0.00

1.2

1.3

—

(3018418) pH of Serum or Plasma

186

1.03

0.00

5.7

3.7

7.42

7.40

0.62

140

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

6.74

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.6

—

7.74

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

200.87

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

5.2

—

4.38

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

5.56

—

(36660697) Celiac disease serology panel - Serum

0.92

-0.00

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

88.44

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.0

—

279.34

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

5.2

—

10.50

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.6

—

6.12

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

4.38

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.4

—

1.19

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

208.80

—

(3000492) Spirometry study

0.96

-0.00

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.92

-0.00

1.4

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

2.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

2.27

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

0.00

-0.00

0.0

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.7

—

23.22

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.8

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

15.35

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SUNBURN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SUNBURN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SUNBURN – Sunburn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sunburn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints